Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage, in Advance of Delivery/Birth

NCT06655207 is registered in ClinicalTrials.gov with Baymatob Operations Pty Ltd as lead sponsor.

NCT NCT06655207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06655207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage, in Advance of Delivery/Birth
Lead sponsor
Baymatob Operations Pty Ltd
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 6, 2025
Completion date
July 3, 2026
Enrollment
1,000 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

high risk pregnancy, maternal care patterns, post partum haemorrhage